Publications

Breast (Edinburgh, Scotland)

Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy.

01-08-2015

Ecancermedicalscience

Staff perceptions of change resulting from participation in a European cancer accreditation programme: a snapshot from eight cancer centres.

17-07-2015

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial.

10-06-2015

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Molecular profiling is rather likely to be cost effective.

10-05-2015

BMC research notes

Development of an instrument to analyze organizational characteristics in multidisciplinary care pathways; the case of colorectal cancer.

09-04-2015

PloS one

Measuring the outcome of biomedical research: a systematic literature review.

04-04-2015

Ecancermedicalscience

Report from the OECI Oncology Days 2014.

28-01-2015

JMIR research protocols

Development of MijnAVL, an Interactive Portal to Empower Breast and Lung Cancer Survivors: An Iterative, Multi-Stakeholder Approach.

22-01-2015

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer.

01-11-2014

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy.

01-11-2014

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing.

01-11-2014

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits.

01-11-2014

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients.

01-11-2014

Ecancermedicalscience

Comprehensive cancer centres based on a network: the OECI point of view.

18-09-2014

Journal of oncology practice

Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.

01-09-2014

Annals of oncology : official journal of the European Society for Medical Oncology

Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014).

01-09-2014

Breast cancer research and treatment

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms.

01-06-2014

British journal of cancer

The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands.

18-02-2014

European journal of cancer (Oxford, England : 1990)

Prospective cost-effectiveness analysis of genomic profiling in breast cancer.

01-12-2013

Journal of translational medicine

Assessing excellence in translational cancer research: a consensus based framework.

29-10-2013

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Value of research and value of development in early assessments of new medical technologies.

21-08-2013

International journal of cancer

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.

15-08-2013

Cancer

The role of comprehensive cancer centers in survivorship care.

01-06-2013

Journal of medical Internet research

A systematic review of web-based interventions for patient empowerment and physical activity in chronic diseases: relevance for cancer survivors.

20-02-2013

The oncologist

Critical appraisal of translational research models for suitability in performance assessment of cancer centers.

25-12-2012

European journal of radiology

Reducing the throughput time of the diagnostic track involving CT scanning with computer simulation.

01-11-2012

BMC research notes

Scenario drafting to anticipate future developments in technology assessment.

16-08-2012

BMC health services research

Exploring improvements in patient logistics in Dutch hospitals with a survey.

01-08-2012

BMC medical informatics and decision making

A review on the relation between simulation and improvement in hospitals.

14-03-2012

Breast cancer research and treatment

Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance.

01-01-2012

BMC cancer

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.

03-11-2011

BMC cancer

Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue.

07-12-2010

BMC health services research

International benchmarking of specialty hospitals. A series of case studies on comprehensive cancer centres.

31-08-2010

European journal of cancer (Oxford, England : 1990)

Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer.

01-05-2010

Molecular oncology

Benchmarking biology research organizations using a new, dedicated tool.

01-02-2010

Molecular oncology

Review on early technology assessments of nanotechnologies in oncology.

01-12-2009

European journal of cancer (Oxford, England : 1990)

Improving the efficiency of a chemotherapy day unit: applying a business approach to oncology.

01-03-2009

International journal of technology assessment in health care

Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.

01-01-2009

Tumori

Early phase Technology Assessment of nanotechnology in oncology.

21-06-2008

The Lancet. Oncology

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

01-12-2007

Journal of health organization and management

Strategic behaviour of institutional providers in mental handicapped care in the Netherlands.

24-08-2007

International journal of technology assessment in health care

Methodology of constructive technology assessment in health care.

12-05-2007

Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy.

Staff perceptions of change resulting from participation in a European cancer accreditation programme: a snapshot from eight cancer centres.

Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial.

Molecular profiling is rather likely to be cost effective.

Development of an instrument to analyze organizational characteristics in multidisciplinary care pathways; the case of colorectal cancer.

Measuring the outcome of biomedical research: a systematic literature review.

Report from the OECI Oncology Days 2014.

Development of MijnAVL, an Interactive Portal to Empower Breast and Lung Cancer Survivors: An Iterative, Multi-Stakeholder Approach.

Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer.

Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy.

Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing.

Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits.

Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients.

Comprehensive cancer centres based on a network: the OECI point of view.

Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.

Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014).

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms.

The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands.

Prospective cost-effectiveness analysis of genomic profiling in breast cancer.

Assessing excellence in translational cancer research: a consensus based framework.

Value of research and value of development in early assessments of new medical technologies.

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.

The role of comprehensive cancer centers in survivorship care.

A systematic review of web-based interventions for patient empowerment and physical activity in chronic diseases: relevance for cancer survivors.

Critical appraisal of translational research models for suitability in performance assessment of cancer centers.

Reducing the throughput time of the diagnostic track involving CT scanning with computer simulation.

Scenario drafting to anticipate future developments in technology assessment.

Exploring improvements in patient logistics in Dutch hospitals with a survey.

A review on the relation between simulation and improvement in hospitals.

Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance.

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.

Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue.

International benchmarking of specialty hospitals. A series of case studies on comprehensive cancer centres.

Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer.

Benchmarking biology research organizations using a new, dedicated tool.

Review on early technology assessments of nanotechnologies in oncology.

Improving the efficiency of a chemotherapy day unit: applying a business approach to oncology.

Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.

Early phase Technology Assessment of nanotechnology in oncology.

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

Strategic behaviour of institutional providers in mental handicapped care in the Netherlands.

Methodology of constructive technology assessment in health care.

This site uses cookies